Aduro Biotech ADRO 深 沪
等待开盘 08-23 09:30:00 美东时间
14.595
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 14.595
- 总市值 2.37亿
- 52周最高 20.20
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 4.505
- 委 比 0.00%
- 总股本 1623.36万
- 历史最高 246.25
- 量 比 0
- 振 幅 0.00%
- 历史最低 4.505
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Adroit Infotech Announces 35th AGM Details
An update from Adroit Infotech Limited ( ($IN:ADROITINFO) ) is now available. A...
08-18 22:12
Adverum Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Pipeline Highlights
Adverum Biotechnologies reported strong progress in the ARTEMIS Phase 3 trial for wet AMD, with enrollment exceeding expectations due to high interest from retina specialists and patients. The trial is expected to complete enrollment in 1Q 2026, with top-line data anticipated in 1H 2027. Two-year follow-up data from the LUNA Phase 2 study will be presented in 4Q 2025. The company completed a $10 million private placement with Frazier Life Science...
08-12 11:00
Aduro Clean Technologies Announces Closing of Underwriter’s Over-Allotment Option in Public Offering
Aduro Clean Technologies Inc. announced the issuance of an additional 142,180 common shares and warrants to purchase 71,090 common shares, raising approximately US$1.2 million through the exercise of the underwriter's over-allotment option. The funds will be used for R&D, construction of a demonstration plant, and general corporate purposes. The Offering was led by D. Boral Capital LLC and made under an effective shelf registration statement with...
06-20 20:33
Aduro Clean Technologies Announces Pricing of US$8 Million Underwritten Public Offering
Aduro Clean Technologies Inc. announced the pricing of an underwritten U.S. public offering of 947,868 common shares with accompanying warrants, raising approximately US$8 million. The offering includes a combined price of US$8.44 per share and half warrant, with each whole warrant exercisable at US$10.13. Proceeds will fund R&D, plant construction, and general corporate purposes. D. Boral Capital LLC is the sole book-running manager, with a 45-d...
06-10 12:00
Advanced Flower Capital Expands Revolving Credit Facility with $20 Million Additional Commitment from Existing FDIC-Insured Banking Partner
<p>Advanced Flower Capital Inc. has expanded its senior secured revolving credit facility to $50 million, with an additional $20 million commitment from its lead arranger. The facility will be used to fund commitments to existing borrowers, originate commercial loans to cannabis operators, and support working capital and general corporate purposes. The facility remains expandable to $100 million. AFC's CEO highlighted the expanded commitment as a...
06-09 20:05
Adroit Infotech Completes Dispatch of Final Call Money Notices
Adroit Infotech Limited ( ($IN:ADROITINFO) ) has shared an update. Adroit Infot...
01-19 02:12
Secondcell Bio to Chair UAE BioTech Symposium in Masdar City, Abu Dhabi
The UAE BioTech Symposium will be hosted in partnership with AmCham Abu Dhabi's BioTech Committee and Masdar City The UAE BioTech Symposium will attract U.S. and international BioTech owners...
2024-09-19 05:06
巴西股市上涨；截至收盘巴西IBOVESPA股指上涨0.25%
© Reuters. 巴西股市上涨；截至收盘巴西IBOVESPA股指上涨0.25% 巴西收盘时，巴西IBOVESPA股指上涨0.25%。 巴西IBOVES...
2024-01-20 05:30
BRIEF-Aduro Biotech Presents Nonclinical, Phase 1 Healthy Volunteer Data For BION-1301
June 2 (Reuters) - Aduro Biotech Inc : * ADURO BIOTECH PRESENTS NO...
2020-06-02 19:39
BRIEF-Aduro Biotech, Chinook Therapeutics Report Definitive Merger Agreement
June 2 (Reuters) - Aduro Biotech Inc : * ADURO BIOTECH AND CHINOOK...
2020-06-02 19:36
